Fulminant hepatitis B following rituximab therapy in a patient with Evans syndrome and large B-cell lymphoma

Am J Hematol. 2006 Apr;81(4):302. doi: 10.1002/ajh.20540.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anemia, Hemolytic, Congenital / complications*
  • Anemia, Hemolytic, Congenital / drug therapy
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Fatal Outcome
  • Hepatitis B / chemically induced*
  • Humans
  • Liver Failure, Acute / chemically induced*
  • Lymphoma, B-Cell / complications*
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, Large B-Cell, Diffuse / complications*
  • Lymphoma, Large B-Cell, Diffuse / drug therapy
  • Male
  • Rituximab
  • Syndrome
  • Thrombocytopenia / complications*
  • Thrombocytopenia / congenital
  • Thrombocytopenia / drug therapy
  • Virus Activation / drug effects

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab